Nautilus Biotechnology, Inc. NAUT
| Name of reporting person | Citizenship or organization | Sole voting power | Shared voting power | Sole dispositive power | Shared dispositive power | Amount beneficially owned | Percent of class | Accepted date |
|---|---|---|---|---|---|---|---|---|
| Cercano Management LLC | Delaware | 0 | 7172985 | 0 | 7172985 | 7172985 | 5.8 % | 13/02/2023 |
| Christopher N. Orndorff | Delaware | 0 | 7172985 | 0 | 7172985 | 7172985 | 5.8 % | 13/02/2023 |
| Cercano Management LLC | Delaware | 0 | 7172985 | 0 | 7172985 | 7172985 | 5.8 % | 13/02/2023 |
| Christopher N. Orndorff | Delaware | 0 | 7172985 | 0 | 7172985 | 7172985 | 5.8 % | 13/02/2023 |
| RA Capital Healthcare Fund, L.P. | Delaware | 0 | 2436430 | 0 | 2436430 | 2436430 | 2 % | 14/02/2022 |
| Rajeev Shah | United States America | 0 | 2436430 | 0 | 2436430 | 2436430 | 2 % | 14/02/2022 |
| RA Capital Management, L.P. | Delaware | 0 | 2436430 | 0 | 2436430 | 2436430 | 2 % | 14/02/2022 |
| Peter Kolchinsky | United States America | 0 | 2436430 | 0 | 2436430 | 2436430 | 2 % | 14/02/2022 |
| Michael Altman | United States | 0 | 4146500 | 0 | 4146500 | 4146500 | 3.3 % | 11/06/2021 |
| Adam Stone | United States | 0 | 4146500 | 0 | 4146500 | 4146500 | 3.3 % | 11/06/2021 |
| ARYA Sciences Holdings III | Cayman Islands | 4146500 | 0 | 4146500 | 0 | 4146500 | 3.3 % | 11/06/2021 |
| BCIP Life Sciences Associates, LP | Delaware | 0 | 108571 | 0 | 108571 | 108571 | 0.7 % | 13/08/2020 |
| Bain Capital Life Sciences Fund II, L.P. | Cayman Islands | 0 | 891429 | 0 | 891429 | 891429 | 5.8 % | 13/08/2020 |